ArticleBMJ open2021

Impact of a 12-week open-label placebo treatment on headache days in episodic and chronic migraine: a study protocol for a parallel-group, multicentre, randomised controlled trial.

Katharina Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.